Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
28.92
-1.04 (-3.47%)
At close: Jul 10, 2026, 4:00 PM EDT
28.90
-0.02 (-0.07%)
After-hours: Jul 10, 2026, 5:21 PM EDT
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$392,679
Profits / Employee
-$613,977
Market Cap
3.64B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 601 | -26 | -4.15% |
| Dec 31, 2024 | 627 | 50 | 8.67% |
| Dec 31, 2023 | 577 | 77 | 15.40% |
| Dec 31, 2022 | 500 | 134 | 36.61% |
| Dec 31, 2021 | 366 | 130 | 55.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Telix Pharmaceuticals | 1,184 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| Catalyst Pharmaceuticals | 182 |
RCUS News
- 1 day ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 9 days ago - Arcus Biosciences announces publication on ARC-20 study research - TheFly
- 9 days ago - New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan - Business Wire
- 4 weeks ago - Arcus Biosciences Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Arcus Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Arcus Biosciences Slides: FY 2026 - Filings
- 5 weeks ago - Arcus Biosciences initiated with an Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Arcus enters clinical trial collaboration, supply agreement with Bristol Myers - TheFly